$BLRX..$.89..good idea there from BioHunter. The company has a market cap of 49m and has 41m in cash now! Their portfolio is very undervalued with solid partnerships with Merck in the area of pancreatic cancer & Immuno-Oncology. Key Milestones right around the corner with September 7-10.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.